SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters
K-Number: K162625 · 2017-06-12
Device Summary
Frequently Asked Questions
What is the SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters?
SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters is a medical device that received FDA 510(k) clearance on 2017-06-12. It is manufactured by B. Braun Interventional Systems, Inc.. The 510(k) number is K162625.
When was SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters approved by the FDA?
SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters received FDA 510(k) clearance on 2017-06-12, under approval number K162625.
What company makes SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters?
SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters is manufactured by B. Braun Interventional Systems, Inc..
What is the FDA product code for SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters?
The FDA product code for SeQuent Neo Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters is LOX.
Related Clinical Trials
Related PubMed Literature
Other Devices by B. Braun Interventional Systems, Inc.
Related Devices (Code: LOX)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.